Stephan A. Hahn

17.8k total citations · 7 hit papers
156 papers, 12.9k citations indexed

About

Stephan A. Hahn is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Stephan A. Hahn has authored 156 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 70 papers in Oncology and 64 papers in Cancer Research. Recurrent topics in Stephan A. Hahn's work include Pancreatic and Hepatic Oncology Research (50 papers), Cancer Genomics and Diagnostics (32 papers) and Genetic factors in colorectal cancer (21 papers). Stephan A. Hahn is often cited by papers focused on Pancreatic and Hepatic Oncology Research (50 papers), Cancer Genomics and Diagnostics (32 papers) and Genetic factors in colorectal cancer (21 papers). Stephan A. Hahn collaborates with scholars based in Germany, United States and United Kingdom. Stephan A. Hahn's co-authors include Mieke Schutte, Ralph H. Hruban, Scott E. Kern, Charles J. Yeo, Craig L. Weinstein, Luís Teixeira da Costa, Wolff Schmiegel, Ester Rozenblum, Christopher A. Moskaluk and Aryeh Fischer and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Stephan A. Hahn

154 papers receiving 12.6k citations

Hit Papers

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromos... 1994 2026 2004 2015 1996 1994 1996 1997 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
    1996 1.9k citations Stephan A. Hahn, Mieke Schutte et al. profile →
  2. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
    1994 912 citations Stephan A. Hahn, Mieke Schutte et al. Nature Genetics profile →
  3. DPC4 gene in various tumor types.
    1996 570 citations Mieke Schutte, Stephan A. Hahn et al. PubMed profile →
  4. Tumor-suppressive pathways in pancreatic carcinoma.
    1997 554 citations Mieke Schutte, Stephan A. Hahn et al. PubMed profile →
  5. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma
    2007 543 citations Bence Sipos, Stephan A. Hahn et al. profile →
  6. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers
    1996 501 citations Sam Thiagalingam, Christoph Lengauer et al. Nature Genetics profile →
  7. Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
    2013 474 citations Stephan A. Hahn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephan A. Hahn Germany 48 7.8k 6.7k 4.7k 2.5k 1.8k 156 12.9k
Thierry Soussi France 62 7.5k 1.0× 7.9k 1.2× 3.2k 0.7× 1.6k 0.6× 971 0.5× 174 13.1k
Hoguen Kim South Korea 53 4.5k 0.6× 4.4k 0.7× 2.3k 0.5× 2.3k 0.9× 2.1k 1.2× 205 10.3k
K W Kinzler United States 25 9.3k 1.2× 8.7k 1.3× 3.3k 0.7× 3.7k 1.5× 735 0.4× 27 14.4k
Riccardo Fodde Netherlands 62 7.9k 1.0× 7.0k 1.0× 4.3k 0.9× 7.2k 2.9× 1.8k 1.0× 176 16.5k
Louis Vermeulen Netherlands 44 5.5k 0.7× 7.1k 1.1× 3.3k 0.7× 1.9k 0.8× 838 0.5× 130 11.5k
Gerard P. Zambetti United States 58 10.6k 1.4× 8.0k 1.2× 3.2k 0.7× 851 0.3× 1.6k 0.9× 133 15.7k
Shikha Bose United States 43 6.3k 0.8× 2.6k 0.4× 2.1k 0.5× 1.6k 0.7× 1.1k 0.6× 109 10.2k
David G. Hicks United States 49 4.4k 0.6× 6.2k 0.9× 3.9k 0.8× 1.3k 0.5× 890 0.5× 185 12.3k
Jeremy R. Graff United States 38 12.0k 1.5× 3.2k 0.5× 2.6k 0.5× 2.2k 0.9× 865 0.5× 84 14.7k
Kathleen R. Cho United States 66 10.5k 1.4× 6.3k 0.9× 4.8k 1.0× 3.5k 1.4× 1.6k 0.9× 152 18.8k

Countries citing papers authored by Stephan A. Hahn

Since Specialization
Citations

This map shows the geographic impact of Stephan A. Hahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan A. Hahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan A. Hahn more than expected).

Fields of papers citing papers by Stephan A. Hahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan A. Hahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan A. Hahn. The network helps show where Stephan A. Hahn may publish in the future.

Co-authorship network of co-authors of Stephan A. Hahn

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan A. Hahn. A scholar is included among the top collaborators of Stephan A. Hahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan A. Hahn. Stephan A. Hahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Ben, Rui Fang, Hendrik Schürmann, et al.. (2025). PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. Cell Reports. 44(4). 115541–115541. 1 indexed citations
2.
Hahn, Stephan A., et al.. (2023). GP‐2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP‐Kinase and impairs the NF‐kB pathway in pancreatic cancer cells. Journal of Cellular and Molecular Medicine. 27(14). 2082–2092. 4 indexed citations
3.
Siegmund, Daniel, et al.. (2021). Unveiling Luminescent IrI and RhI N‐Heterocyclic Carbene Complexes: Structure, Photophysical Specifics, and Cellular Localization in the Endoplasmic Reticulum. Chemistry - A European Journal. 27(22). 6783–6794. 11 indexed citations
4.
Mika, Thomas, Abdelouahid Maghnouj, Susanne Klein‐Scory, et al.. (2020). Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells. Frontiers in Molecular Biosciences. 7. 84–84. 24 indexed citations
5.
Mika, Thomas, Abdelouahid Maghnouj, Susanne Klein‐Scory, et al.. (2020). Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy. Frontiers in Oncology. 10. 568056–568056. 16 indexed citations
6.
Yosef, Hesham K., et al.. (2018). Raman micro-spectroscopy monitors acquired resistance to targeted cancer therapy at the cellular level. Scientific Reports. 8(1). 15278–15278. 30 indexed citations
7.
Sand, Michael, Falk G. Bechara, Daniel Sand, et al.. (2016). Circular RNA Expression in Basal Cell Carcinoma. Epigenomics. 8(5). 619–632. 82 indexed citations
8.
Cioffi, Michele, Sara Maria David Trabulo, Yolanda Sanchez-Ripoll, et al.. (2015). The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. Gut. 64(12). 1936–1948. 120 indexed citations
9.
Kumar, Sanjeev, et al.. (2014). Suppression of soluble adenylyl cyclase protects smooth muscle cells against oxidative stress-induced apoptosis. APOPTOSIS. 19(7). 1069–1079. 17 indexed citations
10.
Sand, Michael, Marina Skrygan, Daniel Sand, et al.. (2012). Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell and Tissue Research. 351(1). 85–98. 121 indexed citations
11.
Neeße, Albrecht, Anke Hahnenkamp, Heidi Griesmann, et al.. (2012). Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Gut. 62(7). 1034–1043. 68 indexed citations
12.
Münding, Johanna, Markus Vogt, Jan Dominik Kuhlmann, et al.. (2011). MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Laboratory Investigation. 91(10). 1472–1479. 97 indexed citations
13.
Smektala, R., Stephan A. Hahn, P. G. Schrader, et al.. (2010). Mediale Schenkelhalsfraktur: Einfluss des Versorgungszeitpunkts auf die Ergebnisqualität : Ergebnisse der Daten der externen stationären Qualitätssicherung im Rahmen sekundärer Datennutzung (Originalien). Der Unfallchirurg. 113(4). 287–292. 9 indexed citations
14.
Chromik, Ansgar M., Stephan A. Hahn, Adrien Daigeler, et al.. (2010). Gene expression analysis of cell death induction by Taurolidine in different malignant cell lines. BMC Cancer. 10(1). 595–595. 10 indexed citations
15.
Emmersen, Jeppe, et al.. (2007). Discarding duplicate ditags in LongSAGE analysis may introduce significant error. BMC Bioinformatics. 8(1). 92–92. 9 indexed citations
16.
17.
Thiagalingam, Sam, Christoph Lengauer, Mieke Schutte, et al.. (1996). Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nature Genetics. 13(3). 343–346. 501 indexed citations breakdown →
18.
Hahn, Stephan A.. (1995). "Der Lübecker Totentanz". Zur rechtlichen und ethischen Problematik der Katastrophe bei der Erprobung der Tuberkuloseimpfung 1930 in Deutschland. 30(1). 61–79. 4 indexed citations
19.
Hahn, Stephan A., et al.. (1989). [The physician of the soul: Albert Moll (1862-1939)].. PubMed. 83(18). 933–5. 2 indexed citations
20.
Hahn, Stephan A.. (1984). [Medical ethics in the life of a physician of the soul--reflections on the medical ethics concept of Albert Moll (1862-1936)].. PubMed. 39(22). 558–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thierry Soussi Breakdown of academic impact, for papers by Hoguen Kim Breakdown of academic impact, for papers by K W Kinzler Breakdown of academic impact, for papers by Riccardo Fodde Breakdown of academic impact, for papers by Louis Vermeulen Breakdown of academic impact, for papers by Gerard P. Zambetti Breakdown of academic impact, for papers by Shikha Bose Breakdown of academic impact, for papers by David G. Hicks Breakdown of academic impact, for papers by Jeremy R. Graff Breakdown of academic impact, for papers by Kathleen R. Cho
Rankless by CCL
2026